ETHICS APPROVAL
The study protocol and informed consent form of this study have been approved by the institutional review board of Huashan Hospital, Fudan University, and registered with the Clinical Trial Platform of the Center for Drug Evaluation, National Medical Products Administration of China (registration no.: CTR20190111). The study was conducted in strict accordance with the principles of the Declaration of Helsinki and Good Clinical Practice, and relevant regulatory requirements.